The cellular pathophysiology of Parkinson's disease remains poorly understood.
Lysosomal homeostasis and protein degradation are affected in Parkinson's disease.
WHAT WE DO
A 360-Degree Perspective for Parkinson's Disease based on Esya's patented DNA nanotechnology, unique biomarkers, and our multiomics platform
If you crave challenges, there's no better place to be
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives touched by Parkinson’s disease, there’s no better place to be.
